Bridgefront Capital, LLC Atri Cure, Inc. Transaction History

Bridgefront Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $244,524 - $327,477	8,668 New	8,668 $263,000
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $223,828 - $294,652	6,240 New	6,240 $258,000
Q2 2022 Aug 12, 2022	SELL	$35.1 - $66.01 $125,552 - $236,117	-3,577 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.43 - $71.39 $205,427 - $255,362	3,577 New	3,577 $235,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.